Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level.

Ogino S, Nishihara R, Lochhead P, Imamura Y, Kuchiba A, Morikawa T, Yamauchi M, Liao X, Qian ZR, Sun R, Sato K, Kirkner GJ, Wang M, Spiegelman D, Meyerhardt JA, Schernhammer ES, Chan AT, Giovannucci E, Fuchs CS.

J Natl Cancer Inst. 2013 Jan 16;105(2):130-40. doi: 10.1093/jnci/djs482. Epub 2012 Nov 21.

2.

Expression profiling of archival tumors for long-term health studies.

Waldron L, Ogino S, Hoshida Y, Shima K, McCart Reed AE, Simpson PT, Baba Y, Nosho K, Segata N, Vargas AC, Cummings MC, Lakhani SR, Kirkner GJ, Giovannucci E, Quackenbush J, Golub TR, Fuchs CS, Parmigiani G, Huttenhower C.

Clin Cancer Res. 2012 Nov 15;18(22):6136-46. doi: 10.1158/1078-0432.CCR-12-1915. Epub 2012 Nov 7.

3.

Physical activity and male colorectal cancer survival.

Meyerhardt JA, Giovannucci EL, Ogino S, Kirkner GJ, Chan AT, Willett W, Fuchs CS.

Arch Intern Med. 2009 Dec 14;169(22):2102-8. doi: 10.1001/archinternmed.2009.412.

4.

Germline polymorphisms in the one-carbon metabolism pathway and DNA methylation in colorectal cancer.

Hazra A, Fuchs CS, Kawasaki T, Kirkner GJ, Hunter DJ, Ogino S.

Cancer Causes Control. 2010 Mar;21(3):331-45. doi: 10.1007/s10552-009-9464-2.

5.

Negative lymph node count is associated with survival of colorectal cancer patients, independent of tumoral molecular alterations and lymphocytic reaction.

Ogino S, Nosho K, Irahara N, Shima K, Baba Y, Kirkner GJ, Mino-Kenudson M, Giovannucci EL, Meyerhardt JA, Fuchs CS.

Am J Gastroenterol. 2010 Feb;105(2):420-33. doi: 10.1038/ajg.2009.578. Epub 2009 Oct 6.

6.

p21 expression in colon cancer and modifying effects of patient age and body mass index on prognosis.

Ogino S, Nosho K, Shima K, Baba Y, Irahara N, Kirkner GJ, Hazra A, De Vivo I, Giovannucci EL, Meyerhardt JA, Fuchs CS.

Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2513-21. doi: 10.1158/1055-9965.EPI-09-0451. Epub 2009 Sep 1.

7.

Interaction of molecular markers and physical activity on mortality in patients with colon cancer.

Meyerhardt JA, Ogino S, Kirkner GJ, Chan AT, Wolpin B, Ng K, Nosho K, Shima K, Giovannucci EL, Loda M, Fuchs CS.

Clin Cancer Res. 2009 Sep 15;15(18):5931-6. doi: 10.1158/1078-0432.CCR-09-0496. Epub 2009 Sep 1.

8.

Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers.

Ogino S, Nosho K, Irahara N, Shima K, Baba Y, Kirkner GJ, Meyerhardt JA, Fuchs CS.

J Clin Oncol. 2009 Sep 20;27(27):4591-8. doi: 10.1200/JCO.2009.22.8858. Epub 2009 Aug 24.

9.

A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis.

Ogino S, Nosho K, Baba Y, Kure S, Shima K, Irahara N, Toyoda S, Chen L, Kirkner GJ, Wolpin BM, Chan AT, Giovannucci EL, Fuchs CS.

Am J Gastroenterol. 2009 Aug;104(8):2047-56. doi: 10.1038/ajg.2009.281. Epub 2009 Jun 9.

10.

DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer.

Nosho K, Shima K, Irahara N, Kure S, Baba Y, Kirkner GJ, Chen L, Gokhale S, Hazra A, Spiegelman D, Giovannucci EL, Jaenisch R, Fuchs CS, Ogino S.

Clin Cancer Res. 2009 Jun 1;15(11):3663-71. doi: 10.1158/1078-0432.CCR-08-2383. Epub 2009 May 26.

11.

Aurora-A expression is independently associated with chromosomal instability in colorectal cancer.

Baba Y, Nosho K, Shima K, Irahara N, Kure S, Toyoda S, Kirkner GJ, Goel A, Fuchs CS, Ogino S.

Neoplasia. 2009 May;11(5):418-25.

12.

PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer.

Ogino S, Nosho K, Kirkner GJ, Shima K, Irahara N, Kure S, Chan AT, Engelman JA, Kraft P, Cantley LC, Giovannucci EL, Fuchs CS.

J Clin Oncol. 2009 Mar 20;27(9):1477-84. doi: 10.1200/JCO.2008.18.6544. Epub 2009 Feb 23.

13.

Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis.

Ogino S, Shima K, Baba Y, Nosho K, Irahara N, Kure S, Chen L, Toyoda S, Kirkner GJ, Wang YL, Giovannucci EL, Fuchs CS.

Gastroenterology. 2009 Apr;136(4):1242-50. doi: 10.1053/j.gastro.2008.12.048. Epub 2008 Dec 24.

14.

JC virus T-antigen in colorectal cancer is associated with p53 expression and chromosomal instability, independent of CpG island methylator phenotype.

Nosho K, Shima K, Kure S, Irahara N, Baba Y, Chen L, Kirkner GJ, Fuchs CS, Ogino S.

Neoplasia. 2009 Jan;11(1):87-95.

15.

Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer.

Ogino S, Kirkner GJ, Nosho K, Irahara N, Kure S, Shima K, Hazra A, Chan AT, Dehari R, Giovannucci EL, Fuchs CS.

Clin Cancer Res. 2008 Dec 15;14(24):8221-7. doi: 10.1158/1078-0432.CCR-08-1841.

16.

A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer.

Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Chan AT, Schernhammer ES, Giovannucci EL, Fuchs CS.

J Natl Cancer Inst. 2008 Dec 3;100(23):1734-8. doi: 10.1093/jnci/djn359. Epub 2008 Nov 25.

17.

Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample.

Nosho K, Irahara N, Shima K, Kure S, Kirkner GJ, Schernhammer ES, Hazra A, Hunter DJ, Quackenbush J, Spiegelman D, Giovannucci EL, Fuchs CS, Ogino S.

PLoS One. 2008;3(11):e3698. doi: 10.1371/journal.pone.0003698. Epub 2008 Nov 12.

18.

Cyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype.

Nosho K, Kawasaki T, Chan AT, Ohnishi M, Suemoto Y, Kirkner GJ, Fuchs CS, Ogino S.

Histopathology. 2008 Nov;53(5):588-98. doi: 10.1111/j.1365-2559.2008.03161.x.

19.

Cohort study of fatty acid synthase expression and patient survival in colon cancer.

Ogino S, Nosho K, Meyerhardt JA, Kirkner GJ, Chan AT, Kawasaki T, Giovannucci EL, Loda M, Fuchs CS.

J Clin Oncol. 2008 Dec 10;26(35):5713-20. doi: 10.1200/JCO.2008.18.2675. Epub 2008 Oct 27.

20.

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.

Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Meyerhardt JA, Loda M, Giovannucci EL, Fuchs CS.

Gut. 2009 Jan;58(1):90-6. doi: 10.1136/gut.2008.155473. Epub 2008 Oct 2.

21.

PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations.

Nosho K, Kawasaki T, Ohnishi M, Suemoto Y, Kirkner GJ, Zepf D, Yan L, Longtine JA, Fuchs CS, Ogino S.

Neoplasia. 2008 Jun;10(6):534-41.

22.

LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer.

Ogino S, Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Kirkner GJ, Fuchs CS.

Int J Cancer. 2008 Jun 15;122(12):2767-73. doi: 10.1002/ijc.23470.

23.

Cyclooxygenase-2 overexpression is common in serrated and non-serrated colorectal adenoma, but uncommon in hyperplastic polyp and sessile serrated polyp/adenoma.

Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Glickman JN, Chan AT, Kirkner GJ, Mino-Kenudson M, Fuchs CS, Ogino S.

BMC Cancer. 2008 Jan 29;8:33. doi: 10.1186/1471-2407-8-33.

24.

CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci.

Kawasaki T, Ohnishi M, Nosho K, Suemoto Y, Kirkner GJ, Meyerhardt JA, Fuchs CS, Ogino S.

Mod Pathol. 2008 Mar;21(3):245-55. doi: 10.1038/modpathol.3800982. Epub 2008 Jan 18.

25.

IGFBP3 promoter methylation in colorectal cancer: relationship with microsatellite instability, CpG island methylator phenotype, and p53.

Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Kirkner GJ, Fuchs CS, Ogino S.

Neoplasia. 2007 Dec;9(12):1091-8.

26.

WRN promoter methylation possibly connects mucinous differentiation, microsatellite instability and CpG island methylator phenotype in colorectal cancer.

Kawasaki T, Ohnishi M, Suemoto Y, Kirkner GJ, Liu Z, Yamamoto H, Loda M, Fuchs CS, Ogino S.

Mod Pathol. 2008 Feb;21(2):150-8. Epub 2007 Dec 14.

27.

Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer.

Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Kirkner GJ, Dehari R, Meyerhardt JA, Fuchs CS, Ogino S.

Neoplasia. 2007 Jul;9(7):569-77.

28.

MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.

Ogino S, Hazra A, Tranah GJ, Kirkner GJ, Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Meyerhardt JA, Hunter DJ, Fuchs CS.

Carcinogenesis. 2007 Sep;28(9):1985-90. Epub 2007 Jul 9.

PMID:
17621591
29.

Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample.

Ogino S, Kawasaki T, Kirkner GJ, Kraft P, Loda M, Fuchs CS.

J Mol Diagn. 2007 Jul;9(3):305-14.

31.

Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.

Ogino S, Kawasaki T, Ogawa A, Kirkner GJ, Loda M, Fuchs CS.

Hum Pathol. 2007 Jun;38(6):842-9. Epub 2007 Mar 12.

PMID:
17350669
32.

Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer.

Ogino S, Kawasaki T, Kirkner GJ, Suemoto Y, Meyerhardt JA, Fuchs CS.

Gut. 2007 Nov;56(11):1564-71. Epub 2007 Mar 5.

33.

TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer.

Ogino S, Kawasaki T, Ogawa A, Kirkner GJ, Loda M, Fuchs CS.

Hum Pathol. 2007 Apr;38(4):614-20. Epub 2007 Jan 31.

PMID:
17270239
35.

Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP.

Ogino S, Kawasaki T, Kirkner GJ, Yamaji T, Loda M, Fuchs CS.

Mod Pathol. 2007 Jan;20(1):15-22. Epub 2006 Nov 3.

36.
37.

Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma.

Ogino S, Odze RD, Kawasaki T, Brahmandam M, Kirkner GJ, Laird PW, Loda M, Fuchs CS.

Am J Surg Pathol. 2006 Sep;30(9):1175-83.

PMID:
16931963
38.

Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer.

Ogino S, Kawasaki T, Kirkner GJ, Ogawa A, Dorfman I, Loda M, Fuchs CS.

J Pathol. 2006 Oct;210(2):147-54.

PMID:
16850502
40.

Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysis.

Ogino S, Brahmandam M, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS.

Mod Pathol. 2006 Aug;19(8):1083-90. Epub 2006 May 12.

41.

Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis.

Ogino S, Kawasaki T, Brahmandam M, Cantor M, Kirkner GJ, Spiegelman D, Makrigiorgos GM, Weisenberger DJ, Laird PW, Loda M, Fuchs CS.

J Mol Diagn. 2006 May;8(2):209-17.

42.

CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies.

Ogino S, Cantor M, Kawasaki T, Brahmandam M, Kirkner GJ, Weisenberger DJ, Campan M, Laird PW, Loda M, Fuchs CS.

Gut. 2006 Jul;55(7):1000-6. Epub 2006 Jan 11.

43.

Urban, rural, and regional variations in physical activity.

Martin SL, Kirkner GJ, Mayo K, Matthews CE, Durstine JL, Hebert JR.

J Rural Health. 2005 Summer;21(3):239-44.

PMID:
16092298
44.

Plasma vitamin D metabolites and risk of colorectal cancer in women.

Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, Giovannucci EL.

Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1502-8.

45.

Metabolic predictors of 5-year change in weight and waist circumference in a triethnic population: the insulin resistance atherosclerosis study.

Mayer-Davis EJ, Kirkner GJ, Karter AJ, Zaccaro DJ.

Am J Epidemiol. 2003 Apr 1;157(7):592-601.

PMID:
12672678
46.

Health care provider counseling for physical activity among black and white South Carolinians.

Granner ML, Liguori G, Kirkner GJ, Ainsworth BE.

J S C Med Assoc. 2001 Aug;97(8):338-41. No abstract available.

PMID:
11534474
47.

Prevalence of physical activity among South Carolina adults.

Drowatzky KL, Brown AS, Kirkner GJ, Ainsworth BE.

J S C Med Assoc. 2001 Aug;97(8):333-7.

PMID:
11534473

Supplemental Content

Loading ...
Support Center